Vaxart, Inc. (VXRT)
0.5016
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Vaxart Total Liabilities (Quarterly) : 82.81M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 82.81M |
| March 31, 2026 | 85.94M |
| December 31, 2025 | 102.67M |
| September 30, 2025 | 182.23M |
| June 30, 2025 | 131.21M |
| March 31, 2025 | 112.94M |
| December 31, 2024 | 107.46M |
| September 30, 2024 | 98.23M |
| June 30, 2024 | 33.74M |
| March 31, 2024 | 32.98M |
| December 31, 2023 | 34.02M |
| September 30, 2023 | 34.12M |
| June 30, 2023 | 37.58M |
| March 31, 2023 | 40.10M |
| December 31, 2022 | 43.25M |
| September 30, 2022 | 53.00M |
| June 30, 2022 | 38.36M |
| March 31, 2022 | 34.01M |
| December 31, 2021 | 33.64M |
| September 30, 2021 | 36.19M |
| June 30, 2021 | 29.06M |
| March 31, 2021 | 29.63M |
| December 31, 2020 | 29.18M |
| September 30, 2020 | 23.03M |
| June 30, 2020 | 23.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 21.27M |
| December 31, 2019 | 24.08M |
| September 30, 2019 | 23.79M |
| June 30, 2019 | 21.40M |
| March 31, 2019 | 23.73M |
| December 31, 2018 | 23.99M |
| September 30, 2018 | 24.65M |
| June 30, 2018 | 25.41M |
| March 31, 2018 | 25.43M |
| June 30, 2017 | 21.40M |
| March 31, 2017 | 22.50M |
| December 31, 2016 | 28.50M |
| September 30, 2016 | 26.50M |
| June 30, 2016 | 26.50M |
| March 31, 2016 | 9.20M |
| December 31, 2015 | 6.70M |
| September 30, 2015 | 7.50M |
| June 30, 2015 | 9.90M |
| March 31, 2015 | 7.30M |
| December 31, 2014 | 11.00M |
| September 30, 2014 | 19.40M |
| June 30, 2014 | 27.10M |
| March 31, 2014 | 24.50M |
| December 31, 2013 | 18.50M |
| September 30, 2013 | 14.10M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.18M |
| Shareholders Equity (Quarterly) | 82.37M |
| Debt to Equity Ratio | 0.1522 |
| Current Ratio | 1.596 |
| Net Debt Paydown Yield | 1.09% |